Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|July 5, 2005
Long-term RNA interference from optimized siRNA expression constructs in adult miceChristine I Wooddell, Cristopher V Van Hout, Thomas Reppen, et al.
Plos One|January 14, 2014
Stochasticity in natural forage production affects use of urban areas by black bears: implications to management of human-bear conflictsSharon Baruch-Mordo, Kenneth R Wilson, David L Lewis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2011
Current status of pharmaceutical and genetic therapeutic approaches to treat DMDChristophe Pichavant, Annemieke Aartsma-Rus, Paula R Clemens, et al.
Pediatrics|July 3, 2003
Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometryDietrich Matern, Miao He, Susan A Berry, et al.
Human Gene Therapy|February 23, 2011
Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNAChristine I Wooddell, Julia O Hegge, Guofeng Zhang, et al.
American Journal of Medical Genetics. Part A|October 18, 2008
The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemiaDavid P Dimmock, Pamela Trapane, Annette Feigenbaum, et al.
Antiviral Research|June 21, 2015
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunitiesRobert G Gish, Bruce D Given, Ching-Lung Lai, et al.
Gastrointestinal Endoscopy|January 11, 2007
Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C-prevalent populationNabiel N Mikhail, David L Lewis, Nabiel Omar, et al.
Clinical Pharmacology in Drug Development|October 15, 2016
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy VolunteersThomas Schluep, Jason Lickliter, James Hamilton, et al.
Nucleic Acid Therapeutics|November 28, 2012
Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivoSo C Wong, Jason J Klein, Holly L Hamilton, et al.
Pageof 7